2-{2-[3-(4-chlorophenyl)-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide
Chemical Structure Depiction of
2-{2-[3-(4-chlorophenyl)-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide
2-{2-[3-(4-chlorophenyl)-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide
Compound characteristics
| Compound ID: | C202-1706 |
| Compound Name: | 2-{2-[3-(4-chlorophenyl)-5-phenyl-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide |
| Molecular Weight: | 488.99 |
| Molecular Formula: | C26 H21 Cl N4 O2 S |
| Smiles: | C1C(c2ccccc2)N(C2=NC(C(CC(Nc3ccccc3)=O)S2)=O)N=C1c1ccc(cc1)[Cl] |
| Stereo: | MIXTURE OF STEREOISOMERS |
| logP: | 5.417 |
| logD: | 5.417 |
| logSw: | -6.1815 |
| Hydrogen bond acceptors count: | 7 |
| Hydrogen bond donors count: | 1 |
| Polar surface area: | 58.972 |
| InChI Key: | WHTNLKANVWOZRW-UHFFFAOYSA-N |